Curvebeam Ai Limited
CVB.ASXHealth Care
Development, manufacture and sale of a range of specialised medical imaging scanners and software aids
Market Data
$0.052
+0.1%$23.4M
-100000.0x
$-0.039
0.00%
-0.5%
Latest Earnings
Appendix 4D - Interim Financial Report - Dec 2025 Half Year
27 February 2026
CurveBeam AI Limited (ASX: CVB) reported HY FY2026 revenue of $4.96M, essentially flat (+1%) versus the prior corresponding period, while its net loss narrowed 6% to $9.84M from $10.52M. The improvement was driven by lower headcount costs following a November 2024 restructure and additional US payroll tax credits, partially offset by higher servicing costs and professional fees related to a new China distribution and licensing deal with WeiYing. The auditor's review includes a going concern paragraph, and with cash of $4.0M at 31 December 2025, liquidity remains a key risk — though a post-period $4M milestone payment from WeiYing provides near-term relief. Key points: Net loss narrowed by $0.68M (6%) to $9.84M, reflecting cost discipline after the November 2024 restructure reduced headcount expenses by $1.11M.; Revenue held steady at $4.96M (+1%), demonstrating resilience in the core WBCT equipment and AI SaaS business.; Completed a $6.5M placement in October 2025 at $0.09/share, providing near-term operating runway.
Recent Announcements
Appendix 4D - Interim Financial Report - Dec 2025 Half Year
CurveBeam AI Limited (ASX: CVB) reported HY FY2026 revenue of $4.96M, essentially flat (+1%) versus the prior corresponding period, while its net loss narrowed 6% to $9.84M from $10.52M. The improvement was driven by lower headcount costs following a November 2024 restructure and additional US payroll tax credits, partially offset by higher servicing costs and professional fees related to a new China distribution and licensing deal with WeiYing. The auditor's review includes a going concern paragraph, and with cash of $4.0M at 31 December 2025, liquidity remains a key risk — though a post-period $4M milestone payment from WeiYing provides near-term relief. Key points: Net loss narrowed by $0.68M (6%) to $9.84M, reflecting cost discipline after the November 2024 restructure reduced headcount expenses by $1.11M.; Revenue held steady at $4.96M (+1%), demonstrating resilience in the core WBCT equipment and AI SaaS business.; Completed a $6.5M placement in October 2025 at $0.09/share, providing near-term operating runway.
Get real-time alerts for CVB
Receive AI-powered earnings summaries and instant notifications when Curvebeam Ai Limited releases results.
Register Free